Table 1 The clinicopathological characteristics of patients with primary operable invasive ductal breast cancer (n=468)
Clinicopathological characteristics | Patients ( n) |
|---|---|
Age (⩽50/>50 years) | 138 (30%)/330 (70%) |
Size (⩽20/21–50/>50 mm) | 280 (60%)/174 (37%)/13 (3%) |
Grade (I/II/III) | 94 (20%)/182 (39%)/192(41%) |
Involved lymph node (0/1–3/>3) | 253(54%)/132 (28%)/78(17%) |
Oestrogen-receptor status (ER−/ER+) | 159 (34%)/283(61%) |
Progesterone-receptor status (PR−/PR+) | 243 (52%)/202 (43%) |
HER-2 status (HER-2−/HER-2+) | 370 (79%)/73 (16%) |
Ki-67 status (low Ki-67/high Ki-67) | 335 (72%)/104 (22%) |
Lymphovascular invasion (absent/present) | 203 (43%)/171 (37%) |
General inflammatory infiltrate (None/mild/moderate/severe) | 30 (6%)/313 (67%)/104 (22%)/21 (5%) |
Loco-regional treatment (Lumpectomy±radiotherapy/mastectomy±radiotherapy) | 179 (38%)/289 (62%) |
Systemic treatment (ER-based treatment; hormonal/hormonal+chemotherapy/chemotherapy/none) | 238 (51%)/92 (20%)/101(22%)/29 (6%) |
